AROVAST F 10/145 TABLET

Product Description

AROVAST F 10/145 TABLET
Advanced Lipid Control with Atorvastatin 10mg + Fenofibrate 145mg

Product Description:
AROVAST F 10/145 TABLET is a powerful lipid-lowering combination of Atorvastatin (10mg) and Fenofibrate (145mg), formulated for effective management of mixed dyslipidemia and elevated triglyceride levels. Atorvastatin helps reduce LDL cholesterol, while Fenofibrate significantly lowers triglycerides and raises HDL cholesterolmaking this combination ideal for patients with combined hyperlipidemia or at high cardiovascular risk.

Manufactured by Agrosaf Pharmaceuticals Pvt. Ltd. in WHO-GMP-certified facilities, AROVAST F 10/145 delivers dependable quality and efficacy for chronic lipid disorder management.

Key Benefits:

• Comprehensive lipid profile improvement in a single tablet

• Reduces LDL, VLDL, and triglyceride levels

• Raises HDL (good cholesterol) for better heart protection

• Ideal for patients with mixed dyslipidemia and metabolic syndrome

• Once-daily oral dosage for better adherence

Therapeutic Indications:

• Mixed hyperlipidemia

• Diabetic dyslipidemia

• Cardiovascular risk reduction in metabolic syndrome

• Adjunct therapy in patients unresponsive to statin monotherapy

Target Buyers:
Tailored for cardiology product wholesalers, hospital pharmacies, diabetic care suppliers, and bulk pharmaceutical buyers seeking combination lipid-lowering medications.

Packaging:
Available in high-quality blister packs with scalable bulk packaging options suitable for hospitals, clinics, and pharmaceutical distributors.

AROVAST F 10/145 TABLET Total lipid care for heart-smart therapy. Brought to you by Agrosaf Pharmaceuticals your trusted B2B partner in cardiovascular and metabolic health solutions